JP2005515192A5 - - Google Patents

Download PDF

Info

Publication number
JP2005515192A5
JP2005515192A5 JP2003546928A JP2003546928A JP2005515192A5 JP 2005515192 A5 JP2005515192 A5 JP 2005515192A5 JP 2003546928 A JP2003546928 A JP 2003546928A JP 2003546928 A JP2003546928 A JP 2003546928A JP 2005515192 A5 JP2005515192 A5 JP 2005515192A5
Authority
JP
Japan
Prior art keywords
ecacc
ddm
cell line
melanoma cell
heterogeneous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003546928A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005515192A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2002/000802 external-priority patent/WO2003045427A2/en
Publication of JP2005515192A publication Critical patent/JP2005515192A/ja
Publication of JP2005515192A5 publication Critical patent/JP2005515192A5/ja
Pending legal-status Critical Current

Links

JP2003546928A 2001-11-29 2002-11-29 ヒト又は動物において免疫応答を誘導するための医薬組成物 Pending JP2005515192A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200101770 2001-11-29
US33670601P 2001-12-07 2001-12-07
PCT/DK2002/000802 WO2003045427A2 (en) 2001-11-29 2002-11-29 Pharmaceutical composition for inducing an immune response in a human or animal

Publications (2)

Publication Number Publication Date
JP2005515192A JP2005515192A (ja) 2005-05-26
JP2005515192A5 true JP2005515192A5 (https=) 2006-01-05

Family

ID=26069102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003546928A Pending JP2005515192A (ja) 2001-11-29 2002-11-29 ヒト又は動物において免疫応答を誘導するための医薬組成物

Country Status (11)

Country Link
US (2) US7771998B2 (https=)
EP (1) EP1448229B1 (https=)
JP (1) JP2005515192A (https=)
AT (1) ATE446106T1 (https=)
AU (1) AU2002365291B2 (https=)
DE (1) DE60234115D1 (https=)
DK (1) DK1448229T3 (https=)
ES (1) ES2335396T3 (https=)
IL (1) IL161832A0 (https=)
RU (1) RU2313365C2 (https=)
WO (1) WO2003045427A2 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ755300A0 (en) 2000-05-17 2000-06-08 Monash University Immune potentiating compositions
DE10112851C1 (de) * 2001-03-16 2002-10-10 Gsf Forschungszentrum Umwelt Semi-allogene Antitumor-Vakzine mit HLA-haplo-identischen Antigen-präsentierenden Zellen
US6982253B2 (en) 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
ATE373727T1 (de) * 2002-11-28 2007-10-15 Peter Kufer Neue real-time rt-pcr methode zur sensitiven detektierung mehrerer mage gen transkripte
CA2587712C (en) * 2004-11-18 2013-02-12 National University Of Corporation Hiroshima University Method and kit for expressing protein under regulation of the expression from repeated sequence formed by gene amplification and transformant
US7700567B2 (en) 2005-09-29 2010-04-20 Supergen, Inc. Oligonucleotide analogues incorporating 5-aza-cytosine therein
WO2007123591A1 (en) * 2006-01-30 2007-11-01 Ludwig Institute For Cancer Research Ctsp cancer-testis antigens
GB0612342D0 (en) * 2006-06-21 2006-08-02 Glaxosmithkline Biolog Sa Method
GB0700284D0 (en) * 2007-01-08 2007-02-14 Glaxosmithkline Biolog Sa Combination therapy
KR101506751B1 (ko) 2007-05-17 2015-03-27 디나벡크 가부시키가이샤 수상세포의 제조방법
US20110313229A1 (en) * 2008-07-24 2011-12-22 Kiminobu Sugaya Therapy Targeting Cancer Stem Cells
RU2573912C2 (ru) * 2008-10-08 2016-01-27 Интрексон Корпорейшн Сконструированные клетки, экспрессирующие множественные иммуномодуляторы, и их применения
CN102625832A (zh) 2009-08-24 2012-08-01 贝勒医学院 产生对多种肿瘤抗原或多种病毒特异的ctl细胞系
KR20130010121A (ko) * 2010-03-23 2013-01-25 인트렉손 코포레이션 치료적 단백질을 조건부로 발현하는 벡터，상기 벡터를 포함하는 숙주 세포 및 이의 용도
GB201013443D0 (en) * 2010-08-11 2010-09-22 Cytovac As Compositions and methods for producing dendritic cells
EP3431142B1 (en) 2011-08-30 2020-06-17 Astex Pharmaceuticals, Inc. Decitabine derivative formulations
SG11201401632WA (en) * 2011-10-20 2014-05-29 California Stem Cell Inc Antigen presenting cancer vaccine
JP5871228B2 (ja) * 2011-10-31 2016-03-01 国立大学法人佐賀大学 慢性副鼻腔炎の検出方法
GB201121308D0 (en) 2011-12-12 2012-01-25 Cell Medica Ltd Process
ES2748652T3 (es) 2012-02-09 2020-03-17 Baylor College Medicine Mezclas pep para generar CTL multivíricos con amplia especificidad
WO2014007669A1 (ru) * 2012-07-04 2014-01-09 Volgushev Sergei Anatolievich Аутологичная клеточная вакцина для лечения онкологических заболеваний и способ ее получения
AU2016287585B2 (en) 2015-07-02 2020-12-17 Otsuka Pharmaceutical Co., Ltd. Lyophilized pharmaceutical compositions
EP3350600A4 (en) 2015-09-18 2019-04-17 Baylor College of Medicine DISTINCTION OF AN IMMUNOGENIC ANTIGEN OF A PATHOGEN AND CORRELATION WITH CLINICAL EFFECTIVENESS
GB201520542D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
RU2020108580A (ru) 2017-08-03 2021-09-03 Оцука Фармасьютикал Ко., Лтд. Лекарственное соединение и способы его очистки
CA3106403A1 (en) 2018-07-15 2020-01-23 Enochian BioPharma, Inc. Methods and compositions using recombinant dendritic cells for cancer therapy
EP3903811A1 (en) 2020-05-01 2021-11-03 R.G.C.C. Holdings AG Pharmaceutical composition and method for inducing an immune response
CA3119597C (en) 2020-10-12 2023-07-11 R.G.C.C. Holdings AG Sars-cov-2 vaccines
EP3981425A1 (en) 2020-10-12 2022-04-13 R.G.C.C. Holdings AG Sars-cov-2 vaccines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443832A (en) * 1990-04-16 1995-08-22 Institut Swisse De Recherches Experimentales Sur Le Cancer Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response
EP1239866A4 (en) * 1999-12-10 2005-02-09 Epimmune Inc INDUCTION OF HER2 / NEU CELLULAR IMMUNE RESPONSES USING PEPTIDE AND NUCLEIC ACID-CONTAINING COMPOSITIONS
US20040241176A1 (en) * 2000-04-27 2004-12-02 Ap Cells. Inc. Method of producing membrane vesicles
EP2149381A3 (en) * 2001-03-09 2010-05-05 Baylor Research Institute Method of treating malignancies through induction of blood immune responses

Similar Documents

Publication Publication Date Title
JP2005515192A5 (https=)
WO2004022709A3 (en) Epitope sequences
JP2020022459A5 (https=)
WO2002081646A3 (en) Epitope sequences
JP2000276471A5 (https=)
JP2007508573A5 (https=)
ATE384785T1 (de) Herstellung von viren, virusisolaten, und impfstoffen
DK1448229T3 (da) Farmaceutisk sammensætning til at inducere et immunrespons hos et menneske eller et dyr
JP2011152135A5 (https=)
JP2002538191A5 (https=)
NO954318L (no) Immunogent preparat av OspC-antigenvaksiner for forhindring og behandling av Lymesykdom, samt rekombinante fremgangsmåter for fremstilling av slike antigener
AU2003240631A8 (en) A t cell subpopulation regulating gut immunity
Saiku et al. Microleakage of a dental amalgam alloy bonding agent.
NO20033967D0 (no) Fremgangsmåte for fremstilling av mikropartikler som inneholder metoprolol
JP2005516004A5 (https=)
WO2004070950A3 (en) Device for encoding a video data stream
Berry et al. Microleakage of amalgam restorations using dentin bonding system primers.
Ramani et al. Limits and degeneracies of discrete Painlevé equations: a sequel
BR0313150A (pt) Cápsulas de gelatina que exibem ligação reticulada reduzida
JP2021077474A5 (https=)
JP2007523200A5 (https=)
CA2210294A1 (en) Immunogenic compositions containing recombinant attenuated poxviruses expressing htlv antigens
SE0302794D0 (sv) Novel microparticles for ultrasound contrast imaging and drug delivery
JP2022507186A5 (https=)
JP2020129755A5 (ja) 画像処理装置及び方法、及び撮像装置